welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Chemoprevention of hereditary colon cancers: time for new strategies
source: Nature Reviews Gastroenterology & Hepatology
year: 2016
authors: Ricciardiello L, Ahnen D J, Lynch P M
summary/abstract:Colorectal cancer (CRC) is potentially preventable. Chemoprevention, a focus of research for the past three decades, aims to prevent or delay the onset of cancer through the regression or prevention of colonic adenomas. Ideal pharmacological agents for chemoprevention should be cheap and nontoxic. Although data indicate that aspirin can reduce the risk of CRC in the general population, the highest return from chemopreventive strategies would be expected in patients with the highest risk of developing the disease, particularly those with a defined hereditary predisposition. Despite compelling data showing that a large number of chemopreventive agents show promise in preclinical CRC models, clinical studies have yielded conflicting results. This Review provides a historical and methodological perspective of chemoprevention in familial adenomatous polyposis and Lynch syndrome, and summarizes the current status of CRC chemoprevention in humans. Our goal is to critically focus on important issues of trial design, with particular attention on the choice of appropriate trial end points, how such end points should be measured, and which patients are the ideal candidates to be included in a chemopreventive trial.
organization: University of Bologna, Italy; University of Colorado, USA; University of Texas MD Anderson Cancer Center, USADOI: 10.1038/nrgastro.2016.56
read more full text source
expertly curated content related to this topic
-
The Proper Diagnostic Pathway of Gardner’s Syndrome: Role of the Dentist in the Early Detection of the Associated ...Gardner’s syndrome is a genetic diseas...
-
Rectal Epithelial Apoptosis does not Predict Response to Sulindac Treatment or Polyp Development in Presymptomatic F...Innormal colorectal epithelium, apoptosi...
-
Iron infusionshttps://www.youtube.com/watch?v=OaFSmO4p...
-
Cancer Prevention Pharmaceuticals, Inc. and Tillotts Pharma AG Sign Licensing Agreement for CPP-1X/sulindac in Europ...Cancer Prevention Pharmaceuticals, Inc. ...
-
Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous P...RATIONALE: Chemoprevention is the us...
-
The Effects of Sulindac on the Pathology of Colorectal Remnant Polyps of Familial Adenomatous Polyposis (FAP) Patien...OBJECTIVE : To evaluate the long-term ef...
-
Single Incision Laparoscopic Surgery in Treating Patients With Colorectal DiseaseThis study is being done to evaluate sin...